These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8830117)

  • 1. T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals.
    Pinto LA; Covas MJ; Victorino RM
    J Med Virol; 1995 Oct; 47(2):139-44. PubMed ID: 8830117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope.
    Gotch F; McAdam SN; Allsopp CE; Gallimore A; Elvin J; Kieny MP; Hill AV; McMichael AJ; Whittle HC
    J Immunol; 1993 Sep; 151(6):3361-9. PubMed ID: 7690804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
    Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
    J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.
    Lonning SM; Zhang W; McGuire TC
    J Virol; 1999 May; 73(5):4257-65. PubMed ID: 10196322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.
    Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G
    J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus.
    Dittmer U; Feldmann G; Sauermann U; Spirng M; Uberla K; Stahl-Hennig C; Hunsmann G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1801-7. PubMed ID: 9680145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope.
    Nixon DF; Huet S; Rothbard J; Kieny MP; Delchambre M; Thiriart C; Rizza CR; Gotch FM; McMichael AJ
    AIDS; 1990 Sep; 4(9):841-5. PubMed ID: 1701304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
    Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
    Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 2 (HIV2).
    Hughes A; Corrah T
    Blood Rev; 1990 Sep; 4(3):158-64. PubMed ID: 2245251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26.
    Geretti AM; Hulskotte EG; Dings ME; van Baalen CA; van Amerongen G; Osterhaus AD
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():821-4. PubMed ID: 9129654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
    Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
    J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
    Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
    J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytotoxic and helper T cell responses by modified simian immunodeficiency virus hypervariable epitope constructs.
    Meyer D; Torres JV
    Viral Immunol; 1999; 12(2):117-29. PubMed ID: 10413358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay.
    Lairmore MD; Hofheinz DE; Letvin NL; Stoner CS; Pearlman S; Toedter GP
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):565-71. PubMed ID: 7688521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
    Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
    Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.